Interleukin 1 and tumor necrosis factor signal transduction mechanisms: potential targets for pharmacological control of inflammation
Related Experiment Videos
1Cytokine Biochemistry Department, Strangeways Research Laboratory, Cambridge, UK.
Abstract:
Interleukin 1 and tumor necrosis factor activate serine/threonine kinase activity in cells within minutes of receptor interaction. Kinases increasing phosphorylation of the small heat shock protein (HSP 27) and epidermal growth factor receptor have been identified and shown to be activated independent of protein kinase A or C. Such kinases are also implicated in activation of the transcription factor nuclear factor kappa B. The cytokines have novel signal transduction pathways that could offer potential therapeutic targets.
Insights
Interleukin 1 and tumor necrosis factor rapidly activate specific kinases, leading to the phosphorylation of key proteins like HSP 27. These pathways, independent of protein kinase A or C, present novel therapeutic targets.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Immunology
Background:
- Interleukin 1 (IL-1) and tumor necrosis factor (TNF) are key inflammatory cytokines.
- Cytokine receptor interactions trigger rapid cellular responses.
- Understanding early signaling events is crucial for therapeutic development.
Purpose of the Study:
- To identify kinases activated by IL-1 and TNF.
- To investigate the role of these kinases in protein phosphorylation.
- To explore the involvement of these pathways in nuclear factor kappa B activation.
Main Methods:
- Cell-based assays to measure kinase activity.
- Western blotting to detect protein phosphorylation.
- Analysis of transcription factor activation.
Main Results:
- IL-1 and TNF rapidly activate serine/threonine kinase activity.
- Phosphorylation of small heat shock protein (HSP 27) and epidermal growth factor receptor is mediated by these kinases.
- Kinase activation is independent of protein kinase A or C.
- These kinases are implicated in nuclear factor kappa B activation.
Conclusions:
- Novel signal transduction pathways are activated by IL-1 and TNF.
- These pathways involve specific kinases and protein phosphorylation.
- The identified pathways represent potential therapeutic targets for inflammatory conditions.